Home
Resources
Publications
Breastfeeding and Migraine Drugs

Breastfeeding and Migraine Drugs

Riccardo Davanzo, Jenny Bua, Giulia Paloni, Giulia Facchina

Eur J Clin Pharmacol. 2014 Nov;70(11):1313-24.

PMID: 25217187

Abstract:

Purpose:
Breastfeeding women may suffer from migraine. While we have many drugs for its treatment and prophylaxis, the majority are poorly studied in breastfeeding women. We conducted a review of the most common anti-migraine drugs (AMDs) and we determined their lactation risk.
Methods:
For each AMD, we collected all retrievable data from Hale's Medications and Mother Milk (2012), from the LactMed database (2014) of the National Library of Medicine, and from a MedLine Search of relevant studies published in the last 10 years.
Results:
According to our review, AMDs safe during breastfeeding are as follows: low-dose acetylsalicylic acid (ASA), ibuprofen, sumatriptan, metoprolol, propranolol, verapamil, amitriptyline, escitalopram, paroxetine, sertraline, acetaminophen, caffeine, and metoclopramide. AMDs compatible with breastfeeding but warranting caution are as follows: diclofenac, ketoprofen, naproxen, most new triptans, topiramate, valproate, venlafaxine, and cyproheptadine. Finally, high-dose ASA, atenolol, nadolol, cinnarizine, flunarizine, ergotamine, methysergide, and pizotifen are contraindicated.
Conclusions:
According to our review, the majority of the revised AMDs were assessed to be compatible with breastfeeding.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP15574966	Pizotifen		15574-96-6	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: